The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Open-label, randomized, multicenter, phase IV trial comparing parenteral nutrition using multi-chamber bags (Eurotubes) versus traditional 2/3-chamber bags in subjects with metastatic or locally advanced inoperable cancer requiring parenteral nutrition: The PEKANNUSS trial of the AIO.
 
Georg Martin Haag
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); EsoCap Biotech; MSD Oncology (Inst)
Speakers' Bureau - SERVIER
Research Funding - MSD Oncology (Inst); Nordic Group (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (Inst); Lilly (Inst)
 
Ralf-Dieter Hofheinz
No Relationships to Disclose
 
Jann Arends
Honoraria - Falk Foundation; Fresenius Kabi; Nutricia; Roche
Consulting or Advisory Role - Baxter/Baxalta/Shire; Nutricia
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Lilly; MSD Oncology; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - Deutsche Forschungsgemeinschaft; Gemeinsamer Bundesausschuss
 
Ingeborg Roetzer
No Relationships to Disclose
 
Hubert Serve
Honoraria - Gilead Sciences; Novartis; Robert-Bosch-Gesellschaft für Medizinische Forschung mbH
Consulting or Advisory Role - Gilead Sciences; IKP Stuttgart
Patents, Royalties, Other Intellectual Property - COMPANION DIAGNOSTICS FOR LEUKEMIA TREATMENT (Inst); MARKERS FOR RESPONSIVENESS TO AN INHIBITOR OF FLT3; Patent on Oncogene Redirection; Patent on Samhd1 modulation for treating resistance to cancer therapy (Inst)
 
Daniel Pink
Employment - Helios Kliniken GmbH
Consulting or Advisory Role - Clinigen Group (Inst); Lilly (Inst); Roche (Inst)
Research Funding - Clinigen Group (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst)
 
Florian Weissinger
Honoraria - Janssen; Novartis; Pfizer; Roche; Sanofi
 
Dirk M. Behringer
No Relationships to Disclose
 
Thomas Zander
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche
 
Kim Barbara Luley
Travel, Accommodations, Expenses - Abbvie; Ipsen; Merck; Sanofi
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Frank Lammert
No Relationships to Disclose
 
Walter Dallacker
No Relationships to Disclose
 
Janine Kreiss-Sender
Consulting or Advisory Role - AstraZeneca; NewConceptOncology; Novartis
 
Buleza Koci
Employment - Eurozyto
Leadership - Eurozyto
 
Daniel Wilhelm Mueller
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Yara Strehler
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Nordic Bioscience; Roche
Speakers' Bureau - AIO gGmbH; Celgene; Forum für Medizinische Fortbildung; Lilly; MCI group; Nordic Bioscience
Research Funding - Celgene; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Lilly; Medac; Merck; Roche; Sanofi; Vifor Pharma